Date	Subject
September 2, 2010	September 2, 2010 Cerus and the Swiss Red Cross Report Successful Outcome of INTERCEPT Blood System Platelet Study
August 24, 2010	August 24, 2010 Cerus Signs Agreement to Acquire INTERCEPT Blood System Asian Commercial Rights from BioOne
July 29, 2010	July 29, 2010 Cerus Corporation Reports Second Quarter Revenues
July 12, 2010	July 12, 2010 Cerus to Release Second Quarter Results on July 29, 2010
June 30, 2010	June 30, 2010 Study Results Presented at International Transfusion Congress Highlight Cerus' Progress Toward Improving the Safety of Platelets, Plasma and Red Blood Cells
May 19, 2010	May 19, 2010 Cerus Appoints William "Obi" Greenman as Chief Business Officer
May 18, 2010	May 18, 2010 Whittemore Peterson Institute and Cerus Confirm Inactivation of XMRV by the INTERCEPT Blood System
April 29, 2010	April 29, 2010 Cerus Corporation Announces First Quarter 2010 Financial Results
April 7, 2010	April 7, 2010 Cerus to Release First Quarter Results on April 29, 2010
April 6, 2010	April 6, 2010 Cerus and Oxford Finance Corporation Enter into $10 Million Growth Capital Credit Facility
March 31, 2010	March 31, 2010 Cerus Signs Agreement with Swiss Red Cross for Deployment of the INTERCEPT Blood System for Platelets
March 2, 2010	March 2, 2010 Cerus to Present at Cowen and Company Annual Health Care Conference
February 23, 2010	February 23, 2010 Cerus Announces Fourth Quarter and Year-End 2009 Results
February 17, 2010	February 17, 2010 Data Presented at International Haemovigilance Seminar Confirm Safety of Cerus' INTERCEPT Blood System for Platelets and Plasma
February 9, 2010	February 9, 2010 Cerus to Collaborate with French National Transfusion Service on INTERCEPT Red Blood Cell Development
February 8, 2010	February 8, 2010 Cerus Corporation Reports Positive Outcome of Phase 1 Clinical Trial of INTERCEPT Red Blood Cells
February 4, 2010	February 4, 2010 Cerus to Release Fourth Quarter and Year-End 2009 Results on February 23, 2010
February 2, 2010	February 2, 2010 Cerus to Present at 12th Annual BIO CEO & Investor Conference
January 14, 2010	January 14, 2010 Cerus Corporation Reports Positive Outcome in European Study of 7-Day INTERCEPT Platelets

Legal |
Privacy